These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9626113)

  • 21. Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism.
    Cordido F; Fernandez T; Martinez T; Peñalva A; Peinó R; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4350-4. PubMed ID: 9851776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central hypothyroidism and its replacement have a significant influence on cardiovascular risk factors in adult hypopituitary patients.
    Klose M; Marina D; Hartoft-Nielsen ML; Klefter O; Gavan V; Hilsted L; Rasmussen AK; Feldt-Rasmussen U
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3802-10. PubMed ID: 23796569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sympathetic response to oral carbohydrate administration. Evidence from microelectrode nerve recordings.
    Berne C; Fagius J; Niklasson F
    J Clin Invest; 1989 Nov; 84(5):1403-9. PubMed ID: 2681266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuation of growth hormone (GH) therapy in GH-deficient patients during transition from childhood to adulthood: impact on insulin sensitivity and substrate metabolism.
    Nørrelund H; Vahl N; Juul A; Møller N; Alberti KG; Skakkebaek NE; Christiansen JS; Jørgensen JO
    J Clin Endocrinol Metab; 2000 May; 85(5):1912-7. PubMed ID: 10843174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
    Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults.
    Aimaretti G; Corneli G; Razzore P; Bellone S; Baffoni C; Arvat E; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 1998 May; 83(5):1615-8. PubMed ID: 9589665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for lower sympathetic nerve activity in young adults with low birth weight.
    Weitz G; Deckert P; Heindl S; Struck J; Perras B; Dodt C
    J Hypertens; 2003 May; 21(5):943-50. PubMed ID: 12714869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gender differences in sympathetic nervous activity: influence of body mass and blood pressure.
    Lambert E; Straznicky N; Eikelis N; Esler M; Dawood T; Masuo K; Schlaich M; Lambert G
    J Hypertens; 2007 Jul; 25(7):1411-9. PubMed ID: 17563563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postprandial triglyceride profile after a standardized oral fat load is altered in growth hormone (GH)-deficient adult patients and is not improved after short-term GH replacement therapy.
    Perotti M; Caumo A; Brunani A; Cambiaghi N; Casati M; Scacchi M; Perra S; Rocco C; Mancia G; Grassi G; Cavagnini F; Pincelli AI
    Clin Endocrinol (Oxf); 2012 Nov; 77(5):721-7. PubMed ID: 22519803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency.
    Maccario M; Aimaretti G; Grottoli S; Gauna C; Tassone F; Corneli G; Rossetto R; Wu Z; Strasburger CJ; Ghigo E
    Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1233-9. PubMed ID: 11477509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle.
    Bramnert M; Segerlantz M; Laurila E; Daugaard JR; Manhem P; Groop L
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1455-63. PubMed ID: 12679422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.
    Thorén M; Hilding A; Brismar T; Magnusson P; Degerblad M; Larsson L; Sääf M; Baylink DJ; Mohan S
    J Bone Miner Res; 1998 May; 13(5):891-9. PubMed ID: 9610754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults.
    Weaver JU; Monson JP; Noonan K; John WG; Edwards A; Evans KA; Cunningham J
    J Clin Endocrinol Metab; 1995 Jan; 80(1):153-9. PubMed ID: 7829604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left ventricular diastolic function abnormalities in hypopituitary patients with GH deficiency: evidence for a subclinical cardiomyopathy.
    Ozbey N; Sezgil A; Oflaz H; Umman B; Orhan Y; Sencer E; Molvalilar S
    J Endocrinol Invest; 2002; 25(7):590-7. PubMed ID: 12150332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circadian and ultradian rhythm and leptin pulsatility in adult GH deficiency: effects of GH replacement.
    Ahmad AM; Guzder R; Wallace AM; Thomas J; Fraser WD; Vora JP
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3499-506. PubMed ID: 11502770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Observational study in adult hypopituitary patients with untreated growth hormone deficiency (ODA study). Socio-economic impact and health status. Collaborative ODA (Observational GH Deficiency in Adults) Group.
    Sanmartí A; Lucas A; Hawkins F; Webb SM; Ulied A
    Eur J Endocrinol; 1999 Nov; 141(5):481-9. PubMed ID: 10576764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relations of total and abdominal adiposity to muscle sympathetic nerve activity in healthy older males.
    Jones PP; Davy KP; Seals DR
    Int J Obes Relat Metab Disord; 1997 Nov; 21(11):1053-7. PubMed ID: 9368830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sympathetic nerve activity and insulin sensitivity in normotensive offspring of hypertensive parents.
    Hausberg M; Sinkey CA; Mark AL; Hoffman RP; Anderson EA
    Am J Hypertens; 1998 Nov; 11(11 Pt 1):1312-20. PubMed ID: 9832174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased sympathetic nerve activity in pulmonary artery hypertension.
    Velez-Roa S; Ciarka A; Najem B; Vachiery JL; Naeije R; van de Borne P
    Circulation; 2004 Sep; 110(10):1308-12. PubMed ID: 15337703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased leptin and tumour necrosis factor alpha per unit fat mass in hypopituitary women without growth hormone treatment.
    Bülow B; Ahrén B; Erfurth EM
    Eur J Endocrinol; 2001 Dec; 145(6):737-42. PubMed ID: 11720898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.